Nova Authorizes a $200 Million Ordinary Share Buyback

Nova (NVMI) said its board approved a new share repurchase program of up to $200 million of the company's ordinary shares, which runs until the full amount is bought back or the program is suspended.

Nova (NASDAQ: NVMI) has given itself permission to buy back as much as $200 million of its own ordinary shares. The company said its board authorized a new repurchase program that stays in force until either the full authorized amount has been bought or the board suspends or terminates it — an open-ended structure with no stated expiry date attached to it.

That framing matters more than it might appear. Many buyback authorizations come with a calendar deadline that forces management to either spend or let the permission lapse. Nova's does not. The constraint is the dollar ceiling, not the clock, which gives the company latitude to sit out expensive stretches and lean in when the share price is weak — the theoretical point of a repurchase program, and the one most companies quietly fail to honor.

Where the shares stand going into the authorization

Nova last traded at 337.64, down 3.10% from the prior close of 348.45, with a session range of 335.47 to 345.43, as of the last trade recorded on Tuesday, 1 September 2026 at 20:00 GMT. Markets are closed; those are closing marks, not live prices.

The drop came on a broadly heavy day for equities. The S&P 500 tracker (SPY) closed at $761.78, off 0.69%; the Nasdaq 100 tracker (QQQ) finished at $707.64, down 1.27%; and the Dow tracker (DIA) ended at $527.75, a 0.72% decline. Nova's fall was therefore roughly two and a half times the Nasdaq 100's on the day — a sharper move than the tape, which is typical of semiconductor-linked names when the index sells off, but a useful reminder of the volatility a buyback is being handed as raw material.

Announcing a repurchase into that kind of session is not, on its own, a signal about the quarter. Boards approve authorizations on a governance calendar, not a market one. But the price context does shape how much stock $200 million actually retires: the lower the average purchase price, the more shares come out of the count for the same money.

What an authorization does and does not commit the company to

A share repurchase authorization is a permission, not a promise. It gives management a board-blessed ceiling to work under; it does not obligate the company to spend a dollar of it. Companies routinely announce programs and then execute slowly, or barely at all, if cash gets earmarked elsewhere — capital equipment, acquisitions, or simply a buffer against a softer demand cycle.

For shareholders, the mechanics are straightforward. Shares bought back reduce the count outstanding, which lifts earnings per share for a given level of net income and concentrates each remaining holder's claim on the business. Unlike a dividend, a buyback is discretionary and can be throttled quarter to quarter without the signaling damage of a dividend cut. That flexibility is precisely why cyclical companies — and semiconductor equipment suppliers are cyclical by nature — tend to favor repurchases over committed payouts.

The offsetting critique is well known: buybacks executed at high prices destroy value as surely as they create it at low ones. The absence of a deadline on Nova's program is, in that light, a point in its favor. It removes the pressure to buy on a schedule.

The disclosure and what has not been said

Nova disclosed the authorization and its $200 million size and the fact that it runs until exhausted or suspended, as reported by Nasdaq Markets. What accompanied the announcement was the ceiling and the duration — not a pace, not a share-count target, and not a stated funding source.

Those omissions are worth cataloguing, because they are the things that determine whether the program moves the needle:

• Execution pace. Whether the company buys steadily in the open market, uses an accelerated structure, or waits for weakness.
• Relation to prior programs. Whether any earlier authorization remains partly unspent, and whether this one replaces or stacks on top of it.
• Offset against dilution. Equity compensation issues new shares every year; some buybacks merely neutralize that rather than shrinking the count.
• Cash and leverage. Whether repurchases are funded from operating cash flow or from the balance sheet.

None of that was quantified in the announcement, and it would be irresponsible to guess at it. The honest read is that $200 million is the number investors have to work with until the company files quarterly detail showing how much was actually spent and at what average price.

What to watch from here

The first genuinely informative datapoint will be the next quarterly disclosure of repurchase activity — the dollar amount executed, the average price paid, and the change in shares outstanding. A program that shows meaningful spend in a quarter when the stock traded near the levels seen at the start of September would suggest management treats weakness as an opportunity. A program that shows minimal activity would suggest the authorization is a standing option rather than an active plan.

Second, watch the interaction with the broader semiconductor tape. Nova's 3.10% decline against a 1.27% fall in the Nasdaq 100 tracker illustrates the beta the company carries into any repurchase decision. High-volatility names give buyback programs more chances to buy cheaply — and more chances to buy expensively if the timing is poor.

Third, watch what the program crowds out. Every dollar committed to repurchase is a dollar not spent on R&D, capacity or acquisitions. In a segment where technology roadmaps move quickly, that trade-off is not trivial, and boards that get it wrong tend to find out several years later.

For now, the fact set is narrow and clean: a board approval, a $200 million ceiling, and no end date. Everything else — pace, funding, effect on the share count — is a matter for the filings that follow.

Key facts

• Buyback authorization: Up to $200 million of ordinary shares
• NVMI last close: 337.64, -3.10% (as of 1 Sep 2026, 20:00 GMT)
• Program duration: Until amount is repurchased, suspended or terminated
• Session range: 335.47–345.43; prior close 348.45

Frequently asked questions

How large is Nova's new buyback program?

Nova's board authorized the repurchase of up to $200 million of the company's ordinary shares. That figure is a ceiling on spending, not a commitment. The company has not disclosed how quickly it intends to execute, what average price it would target, or how many shares $200 million would ultimately retire from the outstanding count.

When does the repurchase program expire?

It has no fixed calendar expiry. Nova said the program remains in effect until the authorized amount has been repurchased, or until the program is suspended or terminated. That structure lets management pause purchases during expensive stretches and step up buying during weakness, rather than spending against a deadline.

Where was NVMI trading when the program was announced?

Nova last traded at 337.64, down 3.10% from a prior close of 348.45, with a session range of 335.47 to 345.43, as of the last recorded trade on 1 September 2026 at 20:00 GMT. Markets were closed at the time of writing, so that is a closing mark rather than a live price.

Does a buyback authorization guarantee shares will be repurchased?

No. An authorization is board permission to spend up to a stated amount, not an obligation. Companies frequently announce programs and then execute slowly or not at all if cash is needed elsewhere. The only reliable evidence of activity is the quarterly disclosure of dollars actually spent and shares actually retired.

How do buybacks benefit shareholders?

Repurchases reduce the number of shares outstanding, which raises earnings per share for a given level of net income and concentrates each remaining holder's ownership stake. Unlike dividends, buybacks are discretionary and can be scaled back without the signaling damage of a payout cut, which suits companies with cyclical earnings.

How did the wider market perform on the same session?

Broad indices fell. The S&P 500 tracker closed at $761.78, down 0.69%; the Nasdaq 100 tracker finished at $707.64, off 1.27%; and the Dow tracker ended at $527.75, down 0.72%. Nova's decline of 3.10% was steeper than all three, reflecting the higher volatility typical of semiconductor-linked shares.

Sources

• Nova Board Authorizes Share Repurchase Program — Nasdaq Markets

Photo: Nic Wood · Pexels Licence — source